Founded in 2010, Novomics develops molecular diagnostic tests for gene analysis in gastric cancer patients, specifically those with stage II-III cancer. Their diagnostic kit enables precise treatment for stomach cancer by leveraging accumulated healthcare knowledge and offering high-quality products and services.